Niraparib in recurrent ovarian cancer Article Letter uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Drug Screening Assays, Antitumor
  • Molecular Targeted Therapy
  • Ovarian Neoplasms
  • Randomized Controlled Trials as Topic
  • Research Design

publication date

  • February 23, 2017

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1056/NEJMc1616633

PubMed ID

  • 28229583

Additional Document Info

start page

  • 801

end page

  • 2

volume

  • 376

number

  • 8